Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

132.44 -0.00 (-0.00%)
Streaming Delayed Price Updated: 1:30 PM EDT, Aug 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
47 48 Next >
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday. 
Via Benzinga
This Is What Whales Are Betting On Abbott Laboratories
 
Via Benzinga
(ABT) - Analyzing Abbott Laboratories's Short Interest
 
Via Benzinga
Apple Taps Seasoned Executive To Head 'Secret' Team Developing Glucose Monitoring Device - Stocks To Watch
Apple Inc (NASDAQ: AAPL) has appointed Tim Millet, a seasoned executive with a background in iPhone and Mac chip technology, to oversee its secretive team dedicated to developing a noninvasive blood... 
Via Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have $300 Today
 
Via Benzinga
Is Abbott Laboratories a Buy?
If you're willing to invest with the right mindset, it could be a great option. 
Via The Motley Fool
Less Is More: Abbott’s Approach to Packaging Innovation
Via ACCESSWIRE
2 Dividend Kings to Buy on the Dip and Hold Forever
Don't ignore these stocks just because the rest of the market is. 
Via The Motley Fool
Why Jim Cramer Warns Investors To Avoid This Stock Up Over 90% This Year
On CNBC’s "Mad Money Lightning Round," Jim Cramer said UiPath Inc. (NYSE: PATH) is a "decent" stock. Cramer said the company is not making money, and he doesn’t recommend stocks that don’t make money. 
Via Benzinga
Could Abbott Laboratories Stock Help You Become a Millionaire?
One promising area of its business is diabetes care, which experienced significant growth this year. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
3 No-Brainer Dividend Stocks to Buy No Matter What the Market Is Doing
You'll want to hold on to these players for the long term. 
Via The Motley Fool
Abbott Joins Billion Dollar Roundtable
Via ACCESSWIRE
Looking At Abbott Laboratories's Recent Unusual Options Activity
 
Via Benzinga
2 Incredible Stocks to Buy on the Dip
Today's bargain may pay off big down the road. 
Via The Motley Fool
$100 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today
 
Via Benzinga
September Rally? 3 Healthcare Stocks to Buy Before Liftoff.
The anticipated volume of future healthcare spending makes this a time to look at healthcare stocks to buy for the long term. 
Via InvestorPlace
The 3 Best Pharma Stocks to Buy Now: September 2023
There are pharma stocks to buy for each type of investor. This article explores the best options in the industry. 
Via InvestorPlace
Down 10.3%, Is Abbott Laboratories Stock a Buy on the Dip?
Its latest pullback could be an opportunity to buy a legendary dividend stock before it begins a long upward climb. 
Via The Motley Fool
The 3 Most Promising Healthcare Stocks to Own Now
These top healthcare stock picks are growing revenues by over 30% due to their game-changing medical device products. 
Via InvestorPlace
Peering Into Abbott Laboratories's Recent Short Interest
 
Via Benzinga
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
These reliable dividend payers are a fantastic opportunity for investors to generate passive income. 
Via The Motley Fool
This Is What Whales Are Betting On Abbott Laboratories
 
Via Benzinga
A Significant Reversal is in Sight for These 5 Med Tech Companies
Med tech stocks are down YOY despite strong secular tailwinds, cash flow, and dividends; the downturn in action is an opportunity and reversal is at hand. 
Via MarketBeat
How Lawmakers Want To Stop Cronobacter Outbreaks That Spurred Baby Formula Shortage Last Year
Under bipartisan Congressional legislation, baby formula manufacturers must notify the U.S. 
Via Benzinga
5 Good Reasons it's Time to Buy High-Yield Dividend King 3M
3M settled the ear plug lawsuit, clearing the path forward. The stock offers investors a high yield and value that may be too hard to pass up 
Via MarketBeat
Topics Lawsuit
1 Stock-Split Stock Billionaires Are Buying Hand Over Fist and 1 Unexpected Stock-Split Stock They're Selling
Some of the world's most successful investors are focusing on stocks. 
Via The Motley Fool
U.S. Credit Rating Concerns? Here Are 3 Stocks to Protect Your Portfolio
Looking for stocks to buy amid the U.S. credit rating downgrade? Look no further. These companies have you covered. 
Via InvestorPlace
Want Growing Passive Income? This Dividend King Could Be a Smart Buy
The company boasts one of the longest dividend growth streaks in the healthcare sector. 
Via The Motley Fool
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
Investors can expect steady returns from these two longtime market-beaters. 
Via The Motley Fool
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
47 48 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS